| Literature DB >> 25755548 |
Pankaj Puri1, Anil C Anand2, Vivek A Saraswat3, Subrat K Acharya4, Radha K Dhiman5, Rakesh Aggarwal3, Shivram P Singh6, Deepak Amarapurkar7, Anil Arora8, Mohinish Chhabra9, Kamal Chetri10, Gourdas Choudhuri11, Vinod K Dixit12, Ajay Duseja5, Ajay K Jain13, Dharmesh Kapoorz14, Premashis Kar15, Abraham Koshy16, Ashish Kumar8, Kaushal Madan17, Sri P Misra18, Mohan V G Prasad19, Aabha Nagral20, Amarendra S Puri21, R Jeyamani22, Sanjiv Saigal17, Shiv K Sarin23, Samir Shah24, P K Sharma25, Ajit Sood26, Sandeep Thareja27, Manav Wadhawan28.
Abstract
Globally, around 150 million people are infected with hepatitis C virus (HCV). India contributes a large proportion of this HCV burden. The prevalence of HCV infection in India is estimated at between 0.5% and 1.5%. It is higher in the northeastern part, tribal populations and Punjab, areas which may represent HCV hotspots, and is lower in western and eastern parts of the country. The predominant modes of HCV transmission in India are blood transfusion and unsafe therapeutic injections. There is a need for large field studies to better understand HCV epidemiology and identify high-prevalence areas, and to identify and spread awareness about the modes of transmission of this infection in an attempt to prevent disease transmission.Entities:
Keywords: CH-C, chronic hepatitis C; GRADE, Grading of Recommendations Assessment, Development and Evaluation; HCV, hepatitis C virus; HIV, human immunodeficiency virus; INASL, Indian National Association for Study of the Liver; IV, intravenous; IVDU, intravenous/injecting drug user; chronic hepatitis; epidemiology; hepatitis C virus
Year: 2014 PMID： 25755548 PMCID： PMC4116733 DOI： 10.1016/j.jceh.2014.05.006
Source DB: PubMed Journal: J Clin Exp Hepatol ISSN： 0973-6883